Title:
ISOQUINOLINESULFONYL CHLORIDE ACID ADDITION SALT AND METHOD FOR PRODUCING SAME
Document Type and Number:
WIPO Patent Application WO/2020/129877
Kind Code:
A1
Abstract:
The present invention provides a compound which is useful as a production intermediate for an isoquinolin-6-sulfonamide compound; and a method for producing the compound. An isoquinolin-6-sulfonyl chloride acid addition salt.
Inventors:
SUMI KENGO (JP)
NAKAMURA RYOHEI (JP)
NAKAMURA RYOHEI (JP)
Application Number:
PCT/JP2019/049100
Publication Date:
June 25, 2020
Filing Date:
December 16, 2019
Export Citation:
Assignee:
D WESTERN THERAPEUTICS INST INC (JP)
International Classes:
C07D217/22; A61K31/472; A61P9/00; A61P25/00; A61P27/02; A61P27/06; C07B61/00
Domestic Patent References:
WO2010146881A1 | 2010-12-23 | |||
WO2012086727A1 | 2012-06-28 | |||
WO2006090783A1 | 2006-08-31 | |||
WO2018030466A1 | 2018-02-15 | |||
WO2010146881A1 | 2010-12-23 | |||
WO2012086727A1 | 2012-06-28 |
Foreign References:
JPS6048936A | 1985-03-16 | |||
JPH1036326A | 1998-02-10 | |||
JPH07247246A | 1995-09-26 | |||
JP2016512203A | 2016-04-25 | |||
JP2005519048A | 2005-06-30 | |||
US20130150339A1 | 2013-06-13 |
Other References:
WEISS, M. M. ET AL.: "Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities", JOURNAL OF MEDICINAL CHEMISTRY, vol. 60, 2017, pages 5969 - 5989, XP055719776
MARCINIEC, K. ET AL.: "Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives", MOLECULES, vol. 22, 2017, pages 300, XP055719778
See also references of EP 3900724A4
MARCINIEC, K. ET AL.: "Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives", MOLECULES, vol. 22, 2017, pages 300, XP055719778
See also references of EP 3900724A4
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: